FX Solutions [FX Shoulder, Inc.] Receives FDA 510k Clearances for TiN Coated Humeral Heads and Glenospheres

TiN Coated Humeral Heads and Glenospheres: FX received 510k clearances for their TiN (Titanium Nitride) Coated Humeral Heads and Glenospheres. The new addition of TiN coated humeral heads and glenospheres adds unique-to-market prostheses to the FX portfolio.

The TiN coated humeral heads and glenospheres are identical to the current humeral heads and glenospheres that we offer but with the TiN coating applied. The TiN coated humeral head is compatible with the Humelock II and Humeris shoulder in the anatomic construct while the TiN coated glenosphere is compatible with the Humelock II®, Humelock Reversed®, and Humeris® shoulder systems in the reverse (or reversible) construct.

Wear testing under worst case load and worst-case environment demonstrated substantial equivalence with the uncoated current CoCr (Cobalt Chromium) products. Other characteristics tested demonstrated no difference in results for those with TiN coating compared to the uncoated product, and there were no TiN particles detected in the analyzed test fluids. FX does not make any claims about the use of these TiN products for patients with nickel allergies.

“We are now able to reach a broad market and provide surgeons even more shoulder arthroplasty solutions to address patients’ needs. As we continue to expand our portfolio, we truly have one of the more comprehensive portfolios dedicated exclusively to shoulder arthroplasty,” said Baptiste Martin, CEO of FX Shoulder USA.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”